-
Anna Miltina Confronted with Racism Allegations on ProSieben Show
-
November Foraging Guide: Edible Mushrooms and Critical Safety Protocols
-
German Auto Giants Face Existential Crisis as China Sales Plummet
-
Microsoft Updates Xbox PC App with 60% Faster Startup and Redesigned Interface
-
Cause of Death Revealed for 'Ellen' Producer Matthew Wright
-
Early Polar Vortex Disruption Creates Uncertain Winter Outlook for Pennsylvania
-
How to Enjoy Luxury Experiences on a Budget
-
Edmund Richardson Wins Baillie Gifford Prize for 'Alexander' Biography
-
Pakistan Demands Grant-Based Climate Finance at COP31 to Avoid Debt Trap
-
BYD Drops Rotating Screens in New Models Due to Tech Limits
-
E Pellicci Pop-Up at Selfridges Brings Back Nostalgic School Cake
-
Ryanair Flight from Rome Makes Emergency Landing in Lisbon After Bomb Threat
-
Coronation Street's Debbie Webster Steps Down as Dementia Storyline Intensifies
US law can't require coverage of HIV prevention drugs, judge rules
A US judge ruled Wednesday in favor of Christian employers who refuse, on religious grounds, to provide workers with health insurance that covers the cost of drugs that help prevent HIV/AIDS.
District Judge Reed O'Connor of a Texas federal court, known for making several rulings hostile to former president Barack Obama's sweeping health care law, took aim at a new aspect of the legislation nicknamed "Obamacare."
The law requires private insurers to reimburse certain preventive care as defined by health authorities. In 2020, they included PrEP -- pills that act to prevent HIV transmission.
Two companies and several individuals went to court to challenge the coverage of the drugs, saying it violates their religious beliefs by making them "complicit in facilitating homosexual behavior," O'Connor said in his decision.
One of the plaintiffs was facing fines of $100 per employee per day for failing to comply with the Obamacare law, said the judge, who ruled that the requirement to reimburse the cost of PrEP pills violates the federal Religious Freedom Restoration Act.
President Joe Biden's Democratic administration will likely appeal the ruling, which was strongly criticized by the leader of the House of Representatives.
"This disturbing decision amounts to open homophobia," House Speaker Nancy Pelosi said in a statement.
PrEP, short for pre-exposure prophylaxis, was approved by the US Food and Drug Administration in 2012 and is now routinely recommended for high-risk people who are HIV-negative to prevent them from becoming infected.
When taken daily, PrEP reduces the risk of infection by 99 percent, but only 23 percent of people who could benefit from it were using the medicine in 2019.
P.M.Smith--AMWN